BackgroundIn patients with acute ST-segment elevation myocardial infarction (STEMI),
the time elapsed from symptom onset to receiving medical care is one of the
main mortality predictors.ObjectiveTo identify independent predictors of late presentation in patients STEMI
representative of daily clinical practice.MethodsAll patients admitted with a diagnosis of STEMI in a reference center between
December 2009 and November 2014 were evaluated and prospectively followed
during hospitalization and for 30 days after discharge. Late presentation
was defined as a time interval > 6 hours from chest pain onset until
hospital arrival. Multiple logistic regression analysis was used to identify
independent predictors of late presentation. Values of p < 0.05 were
considered statistically significant.ResultsA total of 1,297 patients were included, with a mean age of 60.7 ±
11.6 years, of which 71% were males, 85% Caucasians, 72% had a mean income
lower than five minimum wages and 66% had systemic arterial hypertension.
The median time of clinical presentation was 3.00 [1.40-5.48] hours, and
approximately one-quarter of the patients had a late presentation, with
their mortality being significantly higher. The independent predictors of
late presentation were Black ethnicity, low income and diabetes mellitus,
and a history of previous heart disease was a protective factor.ConclusionBlack ethnicity, low income and diabetes mellitus are independent predictors
of late presentation in STEMI. The identification of subgroups of patients
prone to late presentation may help to stimulate prevention policies for
these high-risk individuals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.